Stiripentol in Dravet Syndrome
NCT01533506 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2013-02-28
Summary
The patient has failed all other available agents and has intractable epilepsy due to Dravet Syndrome. Stiripentol is highly efficacious in Dravet Syndrome. The overall goals of therapy with Stiripentol are primarily to significantly reduce the frequency and severity of seizures.
Conditions
Interventions
- DRUG
-
stiripentol
Stiripentol up to 30 mg/kg/day to control seizures
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Elaine Wirrell, MD · Mayo Clinic
Eligibility
- Min Age
- 11 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome
NCT02926898 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
NCT05019885 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
NCT04437004 ·Status: APPROVED_FOR_MARKETING
-
Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
NCT05512130 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
BOTOX Effects on Seizure Severity and Susceptibility
NCT05605756 ·Status: TERMINATED ·Phase: PHASE4
-
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
NCT04937062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394 ·Status: RECRUITING ·Phase: PHASE3
-
Study of [11C]DPA-713 for Temporal Lobe Epilepsy
NCT01793532 ·Status: COMPLETED
-
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
NCT01142193 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Cannabidiol for Drug-Resistant Epilepsies
NCT03014440 ·Status: NO_LONGER_AVAILABLE
-
Effect of Valproic Acid Concentration on Photic Response
NCT00609245 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
NCT02607904 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Oral Valproic Acid for Retinitis Pigmentosa
NCT01233609 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiac Arrhythmias in Dravet Syndrome
NCT02415686 ·Status: COMPLETED
-
Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
NCT06794606 ·Status: RECRUITING
-
Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)
NCT07176832 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
NCT05419180 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury
NCT06870240 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Ketamine for the Treatment of Refractory Status Epilepticus
NCT07177235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00232596 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
NCT00535392 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
NCT02607891 ·Status: COMPLETED ·Phase: PHASE2
-
Refractory Status Epilepticus Treatment Study
NCT01586208 ·Status: COMPLETED ·Phase: PHASE3
-
Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
NCT02091375 ·Status: COMPLETED ·Phase: PHASE3
-
Seizures Post Intracerebral Hemorrhage
NCT01115959 ·Status: COMPLETED ·Phase: PHASE4